Impact of crestal and subcrestal implant placement upon changes in marginal peri-implant bone level. A systematic review by Pellicer Chover, Hilario et al.
Med Oral Patol Oral Cir Bucal. 2019 Sep 1;24 (5):e673-83.                                                                                                                                                                   Crestal and subcrestal implants
e673
Journal section: Oral Surgery
Publication Types: Review
Impact of crestal and subcrestal implant placement upon changes in marginal 
peri-implant bone level. A systematic review
Hilario Pellicer-Chover 1, María Díaz-Sanchez 2, David Soto-Peñaloza 2, María Peñarrocha-Diago 3, Luigi 
Canullo 4, David Peñarrocha-Oltra 5
1 DDS, PhD. Collaborating Professor of the Master in Oral Surgery and Implant Dentistry, Oral Surgery Unit, Department of 
Stomatology, Faculty of Medicine and Dentistry, University of Valencia, Spain
2 DDS, Master in Oral Surgery and Implant Dentistry, Department of Stomatology, Faculty of Medicine and Dentistry, University 
of Valencia, Spain
3 MD, PhD, DDS. Full Professor, Oral Surgery Unit, Department of Stomatology, Faculty of Medicine and Dentistry, University 
of Valencia, Spain
4 DDS, PhD. Visiting Professor in Oral Surgery and Implantology, Stomatology Department, Faculty of Medicine and Dentistry, 
University of Valencia, Valencia, Spain




Clínica Odontológica, Unidad de Cirugía Bucal





Background: To systematically assess studies analyzing peri-implant bone loss in implants placed in crestal and 
subcrestal position. 
Material and Methods: Following the recommended methods for systematic reviews and meta-analyses (PRIS-
MA), an electronic search was conducted in the PubMed (MEDLINE), EMBASE and LILACS databases to iden-
tify all relevant articles published up until April 2017. The search included human studies comparing marginal 
bone loss (MBL) between a control group and a study group with a minimum of 10 patients and a minimum 
follow-up of 6 months after prosthetic loading with rough neck implants. Two independent reviewers assessed the 
risk of bias in the selected studies based on the Newcastle-Ottawa scale for observational studies and the Cochrane 
Collaboration for clinical trials.
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Introduction
Many authors (1-3) have observed peri-implant bone 
losses of between 1-2 mm after the first year of occlu-
sal loading, and of 0.1 to 0.2 mm over successive years. 
Such bone loss has been associated to many factors, 
such as the periodontal biotype (4), the distance be-
tween implants (5), macro- and micro-implant design 
(6), and occlusal overloading (7). An additional factor is 
the presence of a microgap prone to microbial contami-
nation in the implant abutment connection and, conse-
quently, the location of this connection in relation to the 
bone crest (8-10).
Placement of an implant in a deeper position with re-
spect to the bone crest (subcrestal placement) has been 
suggested as a method that could contribute to main-
tain the periimplant soft and hard tissues in comparison 
with crestal placement, though this affirmation is sub-
ject to controversy. As early as 1969, Branemark (11) 
recommended placing the implant below the bone crest 
to prevent implant exposure during bone remodeling. 
Some authors (10,12) have reported that implants placed 
approximately 2 mm below the bone crest are associ-
ated with significantly less peri-implant bone loss com-
pared to implants placed at crestal level. Conversely, 
other authors (13-18) have observed greater bone loss 
with implants placed at subcrestal level. Variations in 
study design, implant geometry, surface treatment and 
surgical protocols in implant placement could explain 
the discrepancies in the results of the aforementioned 
studies. 
Initial bone loss from implants has been associated with 
peri-implant bone loss over the long term and therefore 
to periimplantitis (19). At present, there is no consen-
sus on optimal interventions for the treatment of peri-
implantitis (20). Therefore, all implant maintenance 
programs are focused on prevention, that is, meticulous 
oral hygiene practices, careful peri-implant examina-
tion, analysis of risk factors and periodic elimination of 
bacterial deposits from implants (21). In this line, lim-
iting the exposure of the rough surface of the implant 
could be relevant to maintain a correct long-term peri-
implant health. Evidence suggests that the apicocoronal 
Results: Of 342 potentially eligible items, 7 complied with the inclusion criteria. One article was retrieved through 
the manual search. Eight articles were finally included: five experimental and three observational studies. The risk 
of bias assessed by the Cochrane Collaboration and Newcastle-Ottawa showed a high risk of bias. The mean follow-
up period was 21 months (range 6-36 months). In four studies, implants placed in a crestal position presented higher 
MBL than subcrestal implants - the differences being significant in one study, while in three studies, implants placed 
in a subcrestal position presented greater MBL than crestal implants, with significant differences in only one study.
Conclusion: Despite its limitations, the present systematic review did not find better outcomes between crestal and 
subcrestal implant placement, however, new studies will be needed, involving improved designs and the standardiza-
tion of protocols to allow statistical comparisons and the drawing of firm conclusions.
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position influences bone loss, though there are conflict-
ing opinions in this respect. Hence the aim of this inves-
tigation was to systematically review studies analyzing 
peri-implant bone loss in implants placed in crestal and 
subcrestal position.
Material and Methods
The present systematic review was conducted in accor-
dance with the PRISMA (Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses) guidelines. 
-Focus question
The present systematic review is therefore justified, 
with the aim of answering the following pre-specified 
focus question developed in accordance with the rec-
ognized Population, Intervention, Comparison, Out-
come (PICO) format: “Are there differences in terms of 
marginal bone loss (MBL) between the subcrestal and 
juxta-crestal placement of osseointegrated implants in 
patients subjected to dental implant treatment?”
-Search strategy
An electronic search was performed without language 
and time restrictions and up until April 2017 in three 
main databases: the MEDLINE from the United States 
National Library of Medicine (NLM) through PubMed, 
EMBASE and LILACS. The medical subject “MESH” 
terms for PubMed, “EMTREE” for Embase and other 
free-text terms were used and combined whenever pos-
sible in each database. 
In addition, electronic screening of the “grey literature” 
through the System for Information on Grey Literature 
in Europe (SIGLE) - Open Grey (http://www.opengrey.
eu/) was performed as suggested by the AMSTAR 
guideline (22), attempting to minimize potential pub-
lication bias. 
The search strategy in the PubMed database was con-
ducted as follows: 
((((“Dental Implants”[Mesh] OR “Dental Implants, Sin-
gle-Tooth”[Mesh] OR dental implants OR titanium im-
plants OR osseointegrated implants)) AND (subcrestal 
implants OR submerged implants)) AND (crestal im-
plants OR non-submerged implants OR non submerged 
implants OR equicrestal implants OR juxta-crestal im-
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plants)) AND (“Bone Resorption”[Mesh] OR crestal 
bone loss OR marginal bone loss).
-Inclusion and exclusion criteria
 The following criteria were established to select arti-
cles for inclusion in the present review: 
- Randomized clinical trials (RCTs), controlled clinical 
trials and prospective/retrospective cohort studies com-
paring crestal and sub-crestal implant placement
- Assessment of MBL
- Inclusion of at least 10 patients
- A minimum follow-up of 6 months after prosthetic 
loading
- Only studies including implants with a rough neck, 
and with or without platform-switching designs
Literature or narrative reviews, case-control studies, 
cross-sectional studies, case series, case reports, pre-
clinical and in vitro studies, letters to the editor were 
excluded
-Data collection, extraction and management
-Screening and selection of papers
Titles and abstracts of potentially selected records were 
independently screened by two reviewers (H.P.C and 
M.D.S). Full reports were obtained and reviewed inde-
pendently for studies that seemed to meet the inclusion 
criteria. To calibrate the interviewer reliability, percent-
ages of agreement and Cohen’s Kappa coefficients were 
calculated. Disagreements between the authors were 
resolved following discussion and, if unresolved, an-
other researcher (D.P.O.) could be consulted to reach 
consensus. 
-Selection of studies and data extraction
The studies that met the inclusion criteria were pro-
cessed for data extraction, which was conducted by two 
independent researchers (H.P.C. and M.D.S.). The fol-
lowing data were extracted and recorded in duplicate: 
author(s), year of publication, study design and details 
of the participants, intervention(s), MBL and relevant 
outcomes. Predefined data collection spreadsheets were 
employed for the assessment of each publication, and 
disagreements were resolved by discussion with a third 
reviewer (D.S.P.). In the event of missing data, a request 
was sent to the authors, if any. 
-Risk of bias in individual studies 
Two independent reviewers (H.P.C. and M.D.S.) eval-
uated all the included articles. The methodological 
quality of observational studies was assessed with the 
Newcastle-Ottawa Scale (NOS) (23), and the Cochrane 
Collaboration tool for assessing the risk of bias was em-
ployed for the assessment of randomised controlled tri-
als (24).
For each aspect of quality assessment, we scored the 
risk of bias following the recommendations of the Co-
chrane Handbook for Systematic Reviews of Interven-
tions 5.1.0 (http://handbook.cochrane.org). Each entry 
was judged as “yes” (low risk of bias), “no” (high risk 
of bias) or “unclear” (either lack of information or un-
certainty over the potential for bias). 
The criteria included assessment of the followed items: 
1) randomization and allocation methods (i.e., selection 
bias); 2) completeness of follow-up period/incomplete 
outcome data (i.e., attrition bias); 3) masking of patients 
(i.e., performance bias); 4) masking of examiners (i.e., 
detection bias); and 5) selective reporting (i.e., reporting 
bias). Based on these answers, risk of bias was catego-
rized as: 1) low risk of bias if all criteria were met (i.e., 
adequate methods of randomization and allocation con-
cealment, a ‘‘yes’’ answer to all questions about com-
pleteness of follow-up and masking of examiners, and a 
‘‘no’’ answer to selective reporting and other sources of 
bias); 2) unclear risk of bias if one or more criteria were 
partially met (i.e., unclear criteria were set); or 3) high 
risk of bias if one or more criteria were not met. In ad-
dition, we developed a summary of bias appraisal to ex-
plain the reasons underlying judgment for each domain 
across studies (supplementary data file). 
In cohort studies, each item of the scale could be award-
ed one point rated on a scale from 0 (high risk of bias) 
to 9 (low risk of bias). 
The NOS assessed three specific criteria: selection, 
comparability and exposure. Only the item compara-
bility could be awarded two points for a maximum of 
two adjusted confounders in the analysis. According to 
Araújo (25), studies presenting a summarizing score 
above the median are considered to have a low risk of 
bias. Therefore, a high risk of bias was considered in 
the case of a summarizing star score of < 6, and at low 
risk of bias was considered in the case of a star score of 
> 6. Quality was based on the number of stars reached. 
Inter-examiner agreement was ascertained through a 
kappa-test; any disagreement was resolved by discus-
sion, consulting a third advisor (D.S.P.).
Results
-Study selection 
A total of 342 articles were obtained from the electronic 
search. After screening by title and abstract (interview-
er agreement = 95.71%; kappa = 0.61; 95% CI [0.53–
0.69]; p < 0.001), rejecting 183 and selecting 19 titles 
for full-text assessment of eligibility. Seven articles 
finally fulfilled the eligibility criteria; in addition, one 
further title was retrieved from the reference lists of in-
cluded studies (interviewer agreement = 98.10%; kappa 
= 0.95; 95% CI [0.86–1.00]; p < 0.001). The reviewers 
agreement was substantial and almost perfect based on 
Landis and Koch scale. The screening process is shown 
in Figure 1. Of these 8 articles, 5 were RCTs (12,26-
29) and three were prospective cohort studies (30-32); 
of the latter, two articles comprised the same prospec-
tive cohort (30,31). A summary of study characteristics 
is provided in Table 1, 1 continue. The excluded titles, 
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Fig. 1: PRISMA flowchart of searching and selection process of titles during systematic review.
with the reasons for exclusion, are described in Table 2.
-Risk of bias assessment 
Inter-examiner agreement in methodological assess-
ment was almost perfect (kappa index, k = 0.87), ac-
cording to the Landis and Koch scale. The risk of bias 
across included titles was assessed according to the 
Cochrane Collaboration tool (n=5) and NOS for non-
randomized studies (n=3). Several methodological flaws 
were identified: scantiness of data regarding allocation 
concealment, the blinding of participants and person-
nel, and the blinding of outcomes assessment, across 
RCTs. Only one study was considered to present a low 
risk of bias (27) (Fig. 2).
Regarding the observational studies, Cassetta, Di Mam-
bro et al. (30) presented a score of 6 out of 9, another 
article (31), 5 out of 9, and one study (32), 4 out of 9. 
The observational studies therefore showed a high risk 
of bias (Table 3).
-Data extraction
The 7 selected studies (eight articles) comprised 479 
patients, of which 32 could not be analyzed due to 
dropouts occurring during the follow-up period. A 
total of 800 implants were placed, of which 243 were 
crestal implants (30.38%) and 557 subcrestal implants 
(69.63%). The mean follow-up period was 21 months 
(range 6-36 months). Five studies (12,26,27,29,32) ex-
cluded smokers, and three articles (28, 30, 31) excluded 
patients who consumed more than 10 cigarettes a day. 
Six articles (12,29-32) adopted a two-stage approach, 
and all implants were covered with mucosa at the mo-
ment of implant placement. In contrast, one study (26) 
connected healing abutments to the implants at implant 
placement, while another study (27) used an immediate 
loading protocol.
The measurements of marginal bone level versus the 
implant shoulder varied in terms of the methodology 






Patients (n) Implants (n) Location Prosthesis Loading 
Time 
Al amri et al. 
(2016) 
Prospective 23 46 (23 
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M Cassetta, Di 
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Kutan et al. (2015) Randomized 
clinical trial 
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crestal/28 
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33 Maxilla / 23 Mandible Cement 
retained 
3 months 
Koh et al. (2011) Randomized 
pilot study 





















24 24 (12 
crestal/12 
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Mandible NR 6 months 
Pellicer-Chover et 
al. (2016) 
Prospective 23 23 (10 
crestal/13 
subcrestal) 



















Follow-up Baseline Marginal Bone Loss 
in mm 
(Crestal) 








and acid etched 
(SLA) 
36 months At the time of 
placement: 
6 mo 0.03±0.1 
18 mo 0.25±0.1 
36 mo 0.45±0.2 
6 mo 0±0 
18 mo 0.2 ± 0.1 
36 mo 0.3 ± 0.2 
Impladent Morse Taper 
connection 
Sandblasted 








36mo 0.2 ± 0.94 36 mo 0.68 ± 1.38 
Impladent Morse Taper 
connection 
Sandblasted 








60 mo 0.04 ± 1.05 60 mo 0.74 ± 1.38 
Neodent ConoMorse Sandblasted 
and acid etched 
(SLA) 
8 months At the time of 
placement 
4 mo 0.86±0.55                      
8 mo 1.03±0.60 
4 mo 0.50 ± 0.35          
8 mo 0.66 ± 0.38 






36 months Prosthetic 
loading 
3 mo 0.06±0.21               
6 mo 0.15±0.37 
12 mo 0.37±0.36 
36 mo 0.56±0.35 
3 mo 0.43 ± 0.39          
6 mo 0.68 ± 0.39        
12 mo 0.82 ± 0.51      
36 mo 1.21 ± 1.05 
BioHorizon Internal tapered NR 12 months Prosthetic 
loading 









RBM          
(Reabsorbable 
Blast Media) 
12 months At the time of 
placement 
12 mo 0.06 ± 1.11 12 mo 1.22 ± 1.06 
 3	
  4	
Table 1: Characteristics of included studies.
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BoP (%) PD BoP (%) PD 
0 100%/100% 0 Not describe 2.1 +- 0.2 1.2 ± 0.1 (% 
PD > 4 mm) 
1.0 ± 0.08 0.7 ± 0.06 (% 
PD > 4 mm) 
0 95.5% / NR 34 (6 early 
failures/ 28 late 
failures) 
Not describe NR NR NR NR 
0 94.1% / 93% 34 (6 early 
failures/ 28 late 
failures) 
Buser et al. 1990 NR NR NR NR 
NR 100% / NR 0 Not describe < 20% 2.4 mm <20% 2.3 mm 
27 100% / NR 0 Albrektsson et al. 
1986 
46.4 1.78 ± 0.96 
mm 
53.6 1.78 ± 0.79 
mm 
3 95.8%/95.8% 1 Not describe NR NR NR NR 
NR NR NR Not describe NR NR NR NR 
2 NR / 100% 0 Buser et al. 1990 NR NR NR NR 
Table 1 continue: Characteristics of included studies.
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Author/year Reasons
Aimetti et al. (2015) Does not compare bone loss of implants in crestal vs. subcrestal position
Astrand et al. (1996, 2002) Does not compare bone loss of implants in crestal vs. subcrestal position
Bergkvist et al. (2004) Does not compare bone loss of implants in crestal vs. subcrestal position
Bhardwaj et al. (2016) Does not compare bone loss of implants in crestal vs. subcrestal position
Brägger et al. (1998) Out of topic
Broggini et al. (2006) Does not compare bone loss of implants in crestal vs. subcrestal position
Ercoli et al. (2017) Does not compare bone loss of implants in crestal vs. subcrestal position
Koutouzis et al. (2014) Does not compare bone loss of implants in crestal vs. subcrestal position
Romanos et al. (2015) Polished neck implants
Stein et al. (2009) Does not compare bone loss of implants in crestal vs. subcrestal position
Veis et al. (2010) External connection
Table 2: Articles excluded with reasons in the present systematic review.
Fig. 2: Summary of the risk of bias on the trial studies included in the systematic review according to the Cochrane Collaboration’s Tool. Low 
risk of bias (green); high risk of bias (red).
used. In four articles (26,29-31) the mean mesial and 
distal marginal bone loss was expressed with positive 
values if the marginal bone was in a coronal position at 
the implant shoulder; as zero value if the marginal bone 
corresponded to the shoulder of the implant; and as neg-
ative values if the marginal bone was apical to the im-
plant shoulder. The rest of the studies did not specify the 
methodology used for the measurement of MBL. The 
baseline reference of the measurements corresponded 
to the moment of implant placement (26,27,29-32) and 
the moment the prosthetic loading (12,28). Peri-implant 
MBL was registered in both groups in all studies. In 
crestal implants, MBL ranged between -0.03 and -1.6 
mm, while in subcrestal implants it ranged between 
0 and -1.4 mm. In four studies (26-28,32), implants 
placed in a crestal position presented higher MBL than 
subcrestal implants - the differences being significant 
in one study (32). On the other hand, in three studies 
(12,29-31), implants placed in a subcrestal position pre-
sented greater MBL than crestal implants, with signifi-
cant differences in only one study (29).
All implants were restored with fixed prostheses, in-
cluding screw-retained (26,28,29), cement-retained 
(12,28,30,31) and hybrid prostheses (27). One article 
(32) failed to report prosthetic restoration.
The present systematic review included studies with in-
ternal connection without platform-switching (28) and 
internal connection with platform-switching, compris-
ing: conical internal connection (12,26,29), morse taper 
connection (27,30,31), and hexagonal internal connec-
tion (32).
Four reports offered percentage success criteria: 100% 
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Table 3: Summary of the risk of bias of the cohort studies included in the systematic review according to the NOS.
(26, 29), 93% (31) and 95.8% (28). On the other hand, 
6 articles reported percentage survival criteria: 100% 
(12,26,27), 95.5% (28), 94.1% (30) and 95.8% (30).
Three studies (12,26,27) included the analysis of periim-
plant soft tissues in their protocols. The variables analyzed 
were: probing depth (12,26,27), modified plaque index 
(12), keratinized tissue width and thickness (27), bleeding 
on probing (12,26,27) and the Löe and Silness gingival 
index (12). No differences in the variables analyzed were 
observed between the crestal and subcrestal groups.
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Discussion
The present systematic review aimed to compare 
peri-implant bone changes in internal connection im-
plants with a rough neck and with or without platform-
switching placed in a crestal versus subcrestal position 
in clinical studies. The review comprised data from 8 
articles corresponding to 7 studies: 5 experimental and 
two observational (cohort studies). The prospective 
cohort study (30,31) reported results at different time 
intervals of 36 and 60 months, respectively. Thus, we 
considered assessment and summary of each article as 
an individual study. Only one RCT showed a low risk 
of bias (27). Observational studies presented high risk 
of bias according to the NOS (23). Allocation conceal-
ment, the blinding of participants and outcomes asses-
sor were limitations detected among studies, as well as 
inadequate description of the non-exposed cohort in 
observational studies, and attrition bias with a dropout 
rate of > 20% in one study (31).
The placement of an implant in a subcrestal position has 
been suggested as a method that could contribute to the 
maintenance of hard and soft periimplant tissues com-
pared to a crestal placement – though this affirmation is 
subject to debate. Experimental animal studies (14,17,33) 
and human studies (13,15,34) involving polished neck 
implants have observed that subcrestal implant place-
ment produces an increase in peri-implant bone loss. 
Various experimental studies in animals (35,36) have 
found that low surface roughness (Sa value 0.5-1 μm), 
such as that found in polished neck implants, promotes 
the formation of fibrous capsules around the polished 
surface of the implant and produces a smaller bone-
implant contact area. Conversely, some authors (37-39) 
found that osseointegration could occur on the implant 
platform when positioned 2 mm subcrestal in implants 
with a rough neck design and platform-switching. The 
latter is a design where the diameter of the abutment is 
smaller than the neck of the implant. Such designs have 
been associated with a decrease in periimplant bone 
loss compared to standard platform implants, thanks to 
the internally repositioned implant-abutment junction 
(mismatching), which limits periimplant bone loss by 
distancing bacteria and infiltrating inflammatory cells 
away from adjacent crestal bone (6). The differences in 
bone loss results among authors can also be attributed 
to the type of prosthetic connection or the type of res-
toration involved (19). A recent systematic review (40) 
claimed the superiority of conical connections in seal-
ing, microgap formation, torque maintenance and sta-
bility of the prosthetic abutment. These finding suggest 
that macro- and micro-designing of the implant could 
play an important role in marginal periimplant bone 
changes when the implants are placed subcrestally.
The results of our systematic review showed exposed 
rough surface around subcrestal implants to less pro-
nounced than in the case of crestal implants. In crestal 
implants, periimplant bone remodeling immediately re-
sults in exposure of the rough surface of the implant. 
This does not happen when the implants are placed sub-
crestally, since the starting point of bone is above the 
implant platform, and the surface is contained within 
the periimplant defect produced by drilling. Therefore, 
bone remodeling does not necessarily lead to exposure 
of the rough surface of the implant. This fact justifies 
the study of the variable “exposed rough surface”. Küt-
an et al. (12) found mean radiographic vertical bone loss 
in the crestal group after three years to be significantly 
smaller than in subcrestal group (0.56±0.35 mm and 
1.21±1.05 mm, respectively), though reabsorption did 
not reach the implant threading. In the control group, 
the first bone-implant contact was located under the lev-
el of the first threads. Pellicer-Chover et al. (29), after 12 
months of follow-up, recorded a bone loss of 0.06 mm 
in crestal implants versus 1.22 in subcrestal implants. 
However, on analyzing the exposed rough surface, the 
subcrestal implants presented lower values (mean 0.57 
mm) than the crestal implants (mean 1.13 mm). In this 
same line, Al Amri et al. (30) observed that in contrast 
to implants placed subcrestally, crestal implants pre-
sented bone levels below the platform (-0.45±0.2 mm), 
and therefore exposure of the rough surface of the im-
plant. Since exposed surfaces of the implants could lead 
to complications in peri-implant health, the authors 
suggested that subcrestal placement of the implants is 
preferable.
Four studies reported success criteria of between 93-
100%. In turn, the success/survival criteria across the 
included studies are consistent with those reported by 
Albrektsson et al. (1) and Buser et al. (35) (Table 1). 
Among the 6 articles that reported implant survival, the 
range was 94.1-100%. Six early failures before loading 
and 28 late failures after loading were described - in 
both cases secondary to peri-implant tissue infection 
(30,31). 
The results referred to soft tissue outcomes in the pres-
ent study should be interpreted with caution, since such 
soft tissue measurements were reported in only three 
studies (12,26,27), and with important heterogeneity 
in the approaches used to assess the parameters among 
studies. Al Amri et al. (26), in crestal implants, found 
the highest mean percentage of sites with bleeding on 
probing and probing depth ≥ 4 mm to be recorded at 6 
months (7.4% and 1.4%, respectively). In subcrestal im-
plants, the highest mean percentage of sites that showed 
bleeding on probing and probing depth ≥ 4 mm was re-
corded at 6 months (2.4% and 1.2%, respectively). In 
contrast, Kütan et al. (12) and De Siqueira et al. (27) 
reported no statistically significant differences between 
the two groups in terms of periodontal indexes.
Study strengths, limitations and recommendations
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To the best of our knowledge, this is the first review that 
assesses the impact of the positioning of crest and sub-
crestal implants in the neck and platform on marginal 
bone loss. Due to the variability in the design and ex-
ecution of the studies, the present work tries to provide 
information for improvement in future studies.
The limitations of our study include the difficulty of 
obtaining data on the type, design (polished or treated 
neck) and connection (conical design, with or without 
platform-switching) of the implants used in each study 
– this resulting in a lack of information that is reflect-
ed in the results of the systematic review. The articles 
included showed variability in their way of measur-
ing marginal bone loss. In this regard, when implants 
are placed subcrestally it may be advisable to report 
the measurements as positive values when the bone is 
above the platform and as negative values when below 
the platform.
Likewise, significant differences were observed in the 
moment of starting to measure bone loss (baseline) - a 
fact that could result in erroneous data. Seven articles 
(26,27,29-32) defined the moment of implant placement 
as the starting point, while two studies (12,28) started 
measurement at the time of prosthetic loading.
Unfortunately, human studies evaluating the effects of 
apico-coronal implant placement on postsurgical mar-
ginal bone loss are limited. This may be due in part to 
the strict inclusion criteria applied in an attempt to pro-
vide direct and less biased comparisons. Further studies 
on this subject are required, in view of the lack of stan-
dardization found in the articles included in our review. 
Future studies in this field are needed to overcome the 
methodological shortcomings, specifically in relation to 
allocation concealment and blinding of the participants 
in RCTs, with better sample size estimations and ad-
equate statistical power, in order to confirm the trends 
observed in our review. Such studies moreover should 
also address the impact of other risk factors or modi-
fiers such as smoking, alcohol, or controlled systemic 
diseases such as type 2 diabetes.
Despite its limitations, the present systematic review 
did not find better outcomes between crestal and sub-
crestal implant placement. In four studies, implants 
placed in a crestal position presented higher MBL than 
subcrestal implants - the differences being significant in 
one study, while in three studies, implants placed in a 
subcrestal position presented greater MBL than crestal 
implants, with significant differences in only one study. 
The underlying evidence is limited and of low quality, 
so to confirm this finding and determine whether it is 
clinically relevant, new studies are needed, involving 
improved designs and the standardization of protocols 
of variable assessment to allow statistical comparisons. 
Further clinical studies with longer follow-up times and 
larger sample sizes are required to improve our under-
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